Combination treatment with plasmapheresis and sirolimus does not seem to benefit nephrogenic systemic fibrosis.
Tsagalis
G
G
Psimenou
E
E
Laggouranis
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D003131:Combined Modality Therapy; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D054989:Nephrogenic Fibrosing Dermopathy / Q000188:drug therapy* / Q000628:therapy*; D010956:Plasmapheresis; D016891:Polycystic Kidney, Autosomal Dominant / Q000473:pathology / Q000628:therapy*; D006435:Renal Dialysis; D020123:Sirolimus / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D020123:Sirolimus